Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Miriam Germann"'
Autor:
J. Mundhenk, Christian Schwentner, Tilman Todenhöfer, Johannes Mischinger, Miriam Germann, Jörg Hennenlotter, Arnulf Stenzl, Stefan Aufderklamm, Georgios Gakis
Publikováno v:
Journal of Endourology. 27:856-861
Retroperitoneal lymph node dissection (RPLND) is performed in patients with advanced nonseminomatous (NSGCT) germ cell tumors and residual retroperitoneal mass post-chemotherapy. The extent of node dissection remains unclear. Ipsilateral template dis
Autor:
J. Mundhenk, Joerg Hennenlotter, A. Stenzl, Georgios Gakis, Johannes Mischinger, Christian Schwentner, Miriam Germann, T. Todenhöfer, Stefan Aufderklamm
Publikováno v:
Der Urologe. 52:1097-1103
Autor:
Johannes Mischinger, Miriam Germann, Christian Schwentner, Saladin Alloussi, Tilman Todenhöfer, Stefan Aufderklamm, Joerg Seibold, Arnulf Stenzl, Georgios Gakis
Publikováno v:
Journal of Endourology. 27:202-207
Several disposable platforms have been introduced for laparoendoscopic single-site (LESS) surgery. Besides technical issues, cost is one of the main limiting factors for their widespread use. We present our experience with LESS surgery for kidney pat
Autor:
Saladin Alloussi, Miriam Germann, J. Seibold, Georgios Gakis, Tilman Todenhöfer, Christian Schwentner, Johannes Mischinger, Stefan Aufderklamm, Arnulf Stenzl
Publikováno v:
Der Urologe. 52:54-59
Ziel Fur die laparoendoskopische Single-site-Chirurgie („laparoendoscopic single-site surgery“, LESS) sind Einwegsysteme seit langerer Zeit verfugbar. Neben der anspruchsvollen Technik stellen die Kosten einen der limitierenden Faktoren hinsichtl
Publikováno v:
Aktuelle Urologie. 40:351-354
Purpose The optimal treatment options for lower pole stones with a diameter below 15 mm are controversially discussed. Extracorporeal shock wave lithotripsy (ESWL) is non-invasive but is hampered by low stone-free rates and a significant retreatment
Autor:
Tilman Todenhöfer, Stefan Aufderklamm, Jörg Hennenlotter, Miriam Germann, Christian Schwentner, Georgios Gakis, Arnulf Stenzl, Ursula Kühs
Publikováno v:
Journal of cancer research and clinical oncology. 139(1)
To investigate whether a combined application of urine cytology (CYT) and molecular markers for bladder cancer (BC) can predict tumor aggressiveness.The study comprised 2,113 patients who underwent urethrocystoscopy and transurethral resection of the